Cargando…
The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis
OBJECTIVE: The present meta-analysis was conducted to evaluate the efficacy and safety of the application of tranexamic acid (TXA) in patients undergoing high tibial osteotomy (HTO). METHODS: PubMed (MEDLINE), EMBASE, and Cochrane Library were systematically searched for relevant literature from inc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194157/ https://www.ncbi.nlm.nih.gov/pubmed/34116690 http://dx.doi.org/10.1186/s13018-021-02512-4 |
_version_ | 1783706362152222720 |
---|---|
author | Ma, Jimin Lu, Hanli Chen, Xinxing Wang, Dasai Wang, Qiang |
author_facet | Ma, Jimin Lu, Hanli Chen, Xinxing Wang, Dasai Wang, Qiang |
author_sort | Ma, Jimin |
collection | PubMed |
description | OBJECTIVE: The present meta-analysis was conducted to evaluate the efficacy and safety of the application of tranexamic acid (TXA) in patients undergoing high tibial osteotomy (HTO). METHODS: PubMed (MEDLINE), EMBASE, and Cochrane Library were systematically searched for relevant literature from inception until 1 February 2021. A combined searching strategy of subject words and random words was adopted. After testing for potential publication bias and/or heterogeneity, we aggregated variables by using the random-effect model. The primary comparison outcome measures were total blood loss, hemoglobin decrease, drain output, wound complications, thrombotic events, and blood transfusion rate of the TXA group versus control. The meta-analysis was performed using the RevMan 5.3 software. RESULTS: A total of 5 studies were included involving 532 patients. The results showed that there were significant differences in the two groups concerning total blood loss (95% confidence interval [CI] − 332.74 to − 146.46, P < 0.00001), hemoglobin decrease on postoperative day (POD) 1, 2, and 5 (POD 1 95% CI − 1.34 to − 0.63, P < 0.00001; POD 2 95% CI − 1.07 to − 0.68, P < 0.00001; POD 5 95% CI − 1.46 to − 0.84, P < 0.00001), drain output (POD total 95% CI − 195.86 to − 69.41, P < 0.00001) and wound complications (RR = 0.34, 95% CI 0.12 to 0.97, P = 0.04). Nonsignificant differences were found in the incidence of thromboembolic events (RR = 0.46, 95% CI 0.09 to 2.41, P = 0.36) and blood transfusion rate (RR = 0.25, 95% CI 0.03 to 2.27, P = 0.22). CONCLUSIONS: This meta-analysis of the available evidence demonstrated that TXA could reduce total blood loss, hemoglobin decrease, drain output, and wound complications without increasing the incidence of thromboembolic events in patients undergoing HTO. But there is no obvious evidence that TXA could reduce blood transfusion rates. Further studies, including more large-scale and well-designed randomized controlled trials, are warranted to assess the efficacy and safety issues of routine TXA use in HTO patients. |
format | Online Article Text |
id | pubmed-8194157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81941572021-06-15 The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis Ma, Jimin Lu, Hanli Chen, Xinxing Wang, Dasai Wang, Qiang J Orthop Surg Res Systematic Review OBJECTIVE: The present meta-analysis was conducted to evaluate the efficacy and safety of the application of tranexamic acid (TXA) in patients undergoing high tibial osteotomy (HTO). METHODS: PubMed (MEDLINE), EMBASE, and Cochrane Library were systematically searched for relevant literature from inception until 1 February 2021. A combined searching strategy of subject words and random words was adopted. After testing for potential publication bias and/or heterogeneity, we aggregated variables by using the random-effect model. The primary comparison outcome measures were total blood loss, hemoglobin decrease, drain output, wound complications, thrombotic events, and blood transfusion rate of the TXA group versus control. The meta-analysis was performed using the RevMan 5.3 software. RESULTS: A total of 5 studies were included involving 532 patients. The results showed that there were significant differences in the two groups concerning total blood loss (95% confidence interval [CI] − 332.74 to − 146.46, P < 0.00001), hemoglobin decrease on postoperative day (POD) 1, 2, and 5 (POD 1 95% CI − 1.34 to − 0.63, P < 0.00001; POD 2 95% CI − 1.07 to − 0.68, P < 0.00001; POD 5 95% CI − 1.46 to − 0.84, P < 0.00001), drain output (POD total 95% CI − 195.86 to − 69.41, P < 0.00001) and wound complications (RR = 0.34, 95% CI 0.12 to 0.97, P = 0.04). Nonsignificant differences were found in the incidence of thromboembolic events (RR = 0.46, 95% CI 0.09 to 2.41, P = 0.36) and blood transfusion rate (RR = 0.25, 95% CI 0.03 to 2.27, P = 0.22). CONCLUSIONS: This meta-analysis of the available evidence demonstrated that TXA could reduce total blood loss, hemoglobin decrease, drain output, and wound complications without increasing the incidence of thromboembolic events in patients undergoing HTO. But there is no obvious evidence that TXA could reduce blood transfusion rates. Further studies, including more large-scale and well-designed randomized controlled trials, are warranted to assess the efficacy and safety issues of routine TXA use in HTO patients. BioMed Central 2021-06-11 /pmc/articles/PMC8194157/ /pubmed/34116690 http://dx.doi.org/10.1186/s13018-021-02512-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Systematic Review Ma, Jimin Lu, Hanli Chen, Xinxing Wang, Dasai Wang, Qiang The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis |
title | The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis |
title_full | The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis |
title_fullStr | The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis |
title_full_unstemmed | The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis |
title_short | The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis |
title_sort | efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194157/ https://www.ncbi.nlm.nih.gov/pubmed/34116690 http://dx.doi.org/10.1186/s13018-021-02512-4 |
work_keys_str_mv | AT majimin theefficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT luhanli theefficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT chenxinxing theefficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT wangdasai theefficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT wangqiang theefficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT majimin efficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT luhanli efficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT chenxinxing efficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT wangdasai efficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis AT wangqiang efficacyandsafetyoftranexamicacidinhightibialosteotomyasystematicreviewandmetaanalysis |